Neovacs S.A announced that it has entered into financing contract to issue 5,000 convertible bonds, warrants or exchangeable into new and or existing shares with a par value of 10,000 each for gross proceeds of 50,000,000 over a maximum period of 48 months on September 5, 2021. The transaction will include participation from Luxembourg fund an High Growth Opportunities Securitization Fund, member of the Alpha Blue Ocean group. The company will receive broken down into fifty tranches of 100 OCEAEs each, accompanied by share subscription warrants.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EUR | -1.00% | -1.00% | -1.00% |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- ALNEV Stock
- ALNEV Stock
- News NEOVACS
- Neovacs S.A. announced that it expects to receive €50 million in funding